Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

Teens who use or abuse cannabis could be at risk for a number of cardiac arrhythmias, according to research published in the American Journal of Cardiology, including atrial flutter or fibrillation, palpitations and long QT syndrome.

The New York City Department of Health and Mental Hygiene has expanded its Health Bucks program to allow pharmacists to “prescribe” produce to low-income residents with high blood pressure.

A combo of cryoballoon ablation and novel oral anticoagulants might be a more effective treatment route than standard care for obese AFib patients, who, according to an Oct. 4 study, are less likely to benefit from traditional catheter ablation in the long-term.

Evidence published in BMJ Heart last month supports the idea of an “obesity paradox” in heart failure, further complicating a long-running debate as to whether extra weight can be cardioprotective in patients with established CVD.

Low birth weight is associated with poorer health outcomes—including CVD—later in life, according to a study out of West Virginia University.

The Centers for Disease Control and Prevention doubled down on its warnings about vaping products Oct. 3 after new numbers revealed more than 1,000 reports of vaping-related lung illness and 18 fatalities in recent weeks.

Researchers are calling for better implementation of ICD therapy after an analysis of the Swedish HF Registry found the devices to be beneficial—but underused—among patients with HFrEF.